- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05333445
NURSE-led Follow-up in Patients Undergoing CATheter Ablation for Atrial Fibrillation (NURSECAT-AF)
January 8, 2024 updated by: Josep Lluis Mont Girbau, Hospital Clinic of Barcelona
Assessing the Nurse-led Educational Intervention in Patients Undergoing Catheter Ablation for Atrial Fibrillation: a Randomized Controlled Trial
The study aims to examine the effect of nurse-led education program on quality of life, atrial fibrillation (AF) risk factors, AF symptomatology, arrhythmia recurrence rate, and readmission rate after AF catheter ablation.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08028
- Recruiting
- Hospital Clínic
-
Contact:
- Lluis Mont, MD, PhD
- Phone Number: +34932275551
- Email: lmont@clinic.cat
-
Sub-Investigator:
- Alba Cano Valls, RN, MSc
-
Sub-Investigator:
- Eduard Guasch, MD PhD
-
Sub-Investigator:
- Esther Carro, RN MSc
-
Sub-Investigator:
- Jose Luis Puente, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Derivatives from the outpatient clinic of the center itself, as well as patients referred from other centers that have ours as a reference for a first AF ablation procedure.
- Have signed the informed consent.
Exclusion Criteria:
- Patients with cognitive impairment or disorientation.
- Patients with problems of comprehension or expression of Spanish or Catalan.
- Patients who are part of the medical or nursing group.
- Patient with defined heart failure with a left ventricular ejection fraction (LVEF) less than 40% and a NYHA III or IV.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nursing intervention
The NI will be performed at 3 times: face to face between 21 and 7 days before admission, between 7 and 15 days after the date of ablation, and 6 months after the ablation procedure.
|
Education for the management of AF is carried out in a structured way, following the Bowyer model using the following pre-specified subtitles: "How the heart works"; "Causes and risk factors of AF"; "Symptoms of AF";"" Goals of treatment in atrial fibrillation ""; ''preparation for the ablation procedure''; and "Lifestyle Modification".
The technique consists of discussing the main subtitles and adapting the visit line to the needs of each patient
identify risk factors and offer guidance based on management strategies for the specific risk factor in each case
patients will also be provided with a phone number and email to contact the nurse for any concerns outside the designated times within the twelve-month follow-up.
|
Active Comparator: control group
After hospital discharge, all patients will be referred to their primary care physician or cardiologist for follow-up. Patients will receive standard follow-up checks by the medical team will not receive structured education from the nurse. |
standard care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes from the baseline and better score in the validated ASTA questionnaire of the intervention group compared to the control group at 12 months in quality of life of patients .
Time Frame: 12 months
|
We will use the second part of ASTA questionnaire: it consists of 13 questions and the answers are measured using a Likert frequency scale from "Never = 0" to "Always = 4".
Higher scores on this scale represent poorer quality of life.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of patients who have the AF risk factor within normal parameters
Time Frame: 12 months
|
differences between the two groups in number of patients with BMI and/or waist circumference changes from the baseline, better score on the Minnesota Adapted Scale for Physical Exercise, number of patients who do not smoke or drink alcohol, number of patients with positive polysomnography, number of patients with impaired of the analytical parameters of HbA1c, TSH, LDL or Triglycerides.
|
12 months
|
number of participants with re-hospitalisation or emergency room visits for cardiovascular cause
Time Frame: 12 months
|
differences between the two groups in number of patients who come to the emergency room or re-admit after discharge from catheter ablation.
|
12 months
|
number of participants with recurrences at AF rhythm
Time Frame: 12 months
|
number of AF detected by ECG or 24-hour cardiac holter routine at 3, 6 and 12 months.
|
12 months
|
differences between both groups in the score received by the patients in the User Experience Questionnaire based on the Picker-33 Patient Experience Questionnaire
Time Frame: 3 months
|
It consists of 14 closed-ended questions and is performed using a checklist to assign numerical values to subjective satisfaction using a Likert scale from "No = 0" to "Yes, always = 4".
Higher scores on this scale represent greater satisfaction.
An open question has been added so that participants can add their suggestions
|
3 months
|
Differences between both groups in intensity, frequency and severity of symptoms related to AF evaluated with the validated ASTA questionnaire
Time Frame: 12 months
|
differences between both groups in the score obtained in the first part of the validated questionnaire in Spanish and English sensitive for patients with AF.
It will be self-filled by the patient himself.
It consists of 8 questions formulated in 3 different ways: (1) Multiple correct answer multiple choice questions.
(2) Multiple choice questions with only one correct answer.
(3) Checklist for assigning numerical values to frequency using a Likert scale from "Never = 0" to "Always = 4".
Higher scores on this scale represent greater severity of symptoms.
|
12 months
|
differences between both groups in the score obtained in the adapted AFKAT questionnaire patient's knowledge of AF.
Time Frame: 3 months
|
differences between both groups in the Level of knowledge of FA through the AFKAT questionnaire validated in English but adapted and translated into Spanish by our team.
It consists of 25 questions with dichotomous True/False answers.
The more true answers, the better knowledge the participant has.
|
3 months
|
calls and emails received
Time Frame: 12 months
|
Quantify the calls and emails received from patients to the FA nurse.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2022
Primary Completion (Estimated)
March 1, 2024
Study Completion (Estimated)
April 30, 2024
Study Registration Dates
First Submitted
March 25, 2022
First Submitted That Met QC Criteria
April 11, 2022
First Posted (Actual)
April 19, 2022
Study Record Updates
Last Update Posted (Actual)
January 9, 2024
Last Update Submitted That Met QC Criteria
January 8, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NURSECAT-AF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
Abbott Medical DevicesRecruitingAtrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited States, Australia, Belgium, Germany, Spain, Netherlands, France, Austria, Canada, Czechia, Italy, United Kingdom
-
St. George's Hospital, LondonRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited Kingdom
Clinical Trials on educational program
-
Norwegian University of Science and TechnologyCompletedFecal Incontinence | Staffs' AttitudesNorway
-
Universidade Nova de LisboaCompletedAnxiety | Prescription Drug Abuse and DependencyPortugal
-
Medical University of GrazCompleted
-
Universitaire Ziekenhuizen KU LeuvenFund for Scientific Research, Flanders, BelgiumCompletedPain | Breast NeoplasmBelgium
-
University of BarcelonaFundació La Marató de TV3; SHE Foundation; Centro Nacional de Investigaciones... and other collaboratorsActive, not recruitingObesity | Diabetes Mellitus | Cardiovascular HealthSpain
-
Cairo UniversityUnknown
-
National Center for Research Resources (NCRR)Virginia Commonwealth UniversityCompletedSystemic Lupus Erythematosus
-
The University of Texas Health Science Center at...National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Clinica Alemana de SantiagoNot yet recruiting
-
Assiut UniversityRecruiting